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Abstract—The concept of biological age (BA) - although
important in clinical practice - is hard to grasp mainly due
to lack of a clearly defined reference standard. For specific
applications, especially in pediatrics, medical image data are
used for BA estimation in a routine clinical context. Beyond
this young age group, BA estimation is restricted to whole-
body assessment using non-imaging indicators such as blood
biomarkers, genetic and cellular data. However, various organ
systems may exhibit different aging characteristics due to lifestyle
and genetic factors. Thus, a whole-body assessment of the BA
does not reflect the deviations of aging behavior between organs.
To this end, we propose a new imaging-based framework for
organ-specific BA estimation. As a first step, we introduce a
chronological age (CA) estimation framework using deep con-
volutional neural networks (Age-Net). We quantitatively assess
the performance of this framework in comparison to existing
CA estimation approaches. Furthermore, we expand upon Age-
Net with a novel iterative data-cleaning algorithm to segregate
atypical-aging patients (BA 6≈ CA) from the given population.
In this manner, we hypothesize that the remaining population
should approximate the true BA behaviour. For this initial
study, we apply the proposed methodology on a brain magnetic
resonance image (MRI) dataset containing healthy individuals
as well as Alzheimer’s patients with different dementia ratings.
We demonstrate the correlation between the predicted BAs and
the expected cognitive deterioration in Alzheimers patients. A
statistical and visualization-based analysis has provided evidence
regarding the potential and current challenges of the proposed
methodology.
Index Terms—Biological age estimation, deep learning, chrono-
logical age, magnetic resonance imaging.
I. INTRODUCTION
AGE is one of the most important parameters describingindividuals in a medical context. For instance, age has a
significant impact on the establishment of working diagnoses
and the choice of appropriate diagnostic tests [2]. Similarly,
age is also an important parameter influencing therapeutic
decisions in a wide range of clinical situations [3], [4].
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However, age-related biological phenotypes can deviate
significantly between individuals within the same age group.
These observations have motivated the concept of biological
age (BA) in contrast to chronological age (CA) [5]. CA is de-
scribed as the amount of time since the birth of an individual.
Unlike CA, BA is not clearly defined. It can be described as
a measure for the extent of genetic, metabolic and functional
changes in an individual that occur during the process of aging.
Thus, BA can be considered as an extension to the traditional
concept of CA in addition to any organ-specific accelerated
or delayed aging characteristics [6]–[8]. Despite this relatively
imprecise definition, the potential impact of the concept of BA
on patient management is easily conceivable. It is a common
practice for clinicians to assess the overall condition of patients
as part of the clinical examination relative to their respective
age group and incorporate this impression into their medical
decisions. However, these personal estimates are subjective
and not easily quantifiable.
As an expansion to the concept of BA, the notion of organ-
specific BA has been proposed aiming to describe changes in
morphology, biology and function of organ systems that occur
with aging [9]. This concept is based on the rationale that
single organs or organ systems can be affected by different
genetic or environmental factors and, thus, display different
courses of aging. As an example, parameters of pulmonary
function were proposed as measures for lung BA [10].
A large body of research attempts the quantification of BA
using non-imaging data. More specifically, age-dependant vari-
ables such as genetic [5], [6], cellular [7], phenotypic [8], [11]
and epidemiological data [12], blood biomarkers [13], [14]
and physical activity [15] have been used as indicators for the
BA. Traditional approaches rely on classical techniques such
as multiple linear regression (MLR) [16] or the Klemera and
Doubal (KD) method [17], whereas recent works adopt deep
neural networks [18], [19]. The majority of these approaches
utilize large cohort datasets for the prediction of the mortality
risk [20]–[22]. Other methods incorporate CA as ground-truth
labels and examine the relation between the predicted ages and
other health indicators, such as the work ability index (WAI)
[23] and frailty index (FI) [24], for assessing BA.
Nonetheless, the above non-imaging approaches lead to a
whole-body assessment of BA. In that sense, they are not
capable of recognizing the differences in aging characteristics
between individual organ systems. In this context, medical
imaging may potentially provide significant information al-
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(a) Hybrid 3D network model with a stem network followed by a basic building block of two inception blocks and a fire module.
(b) Inception block basic architecture. (c) Fire module basic architecture.
Fig. 1: An overview of the proposed chronological age estimation network (Age-Net) with the detailed architecture of each block. The
network takes as an input either the whole organ volume or volume chunks of segmented brain gray matter (GM). The dimensions of the
separate blocks are the same regardless the feeding strategy (full/chunks).
lowing for non-invasive estimation of organ-specific BA.
The use of medical imaging for age estimation in a clinical
setting is limited mainly to skeletal age estimation in infants
and adolescents using conventional radiography and MRI
[25]–[28]. Beyond skeletal age estimation, first studies have
introduced the concept of brain age based on changes in
brain morphology (e.g. changes in subvolumes) and provided
evidence for associations between premature brain aging and
cognitive function [29], [30]. Brain age can be defined by
comparing an individuals morphological brain features to a
reference data base of the underlying population. This is
possible using brain MRI due to the highly constant anatomy
of the central nervous system that allows for detection of age-
dependent morphological deviations. Similarly, Alzheimers
disease was found to correlate directly with abnormal brain
aging [31].
More recent efforts have incorporated the use of machine
learning (ML) and deep learning (DL) techniques for medical
imaging-based age estimation. Traditional approaches, such
as kernel methods [32] and support vector machines (SVMs)
[33], were initially utilized for brain CA estimation using
T1-weighted MRI volumes. Also, atlas-based methods were
employed to extract effective local features for the same task
[34]. However, in recent years, the use of convolutional neural
networks (CNNs) has become more prevalent due to strong
results in a multitude of medical tasks, such as classification
and segmentation [35]–[38]. For instance, a deep CNN has
been utilized for prediction of brain age using 2D T1-weighed
MR images [39]. This framework was then expanded upon to
incorporate manually extracted features in addition to the 2D
CNN architecture [40]. Recent advances have attempted the
use of relatively shallow 3D CNN architectures to incorporate
the spatial information between slices in the brain age esti-
mation procedure [41], [42]. For forensic applications, a large
body of research has utilized hand and skeletal MRI volumes
to estimate the BA [42]–[45].
As stated clearly in the most recent survey on this topic [46],
all DL approaches, whether imaging or non-imaging based,
relies on the CA as ground-truth labels for BA prediction [41],
[47]. Thus, the predicted ages cannot be used to assess the true
aging characteristics of the test subjects. To the best of our
knowledge, the problem of defining BA ground-truth labels is
still not possible and remains an open research question.
The purpose of this study is to bridge the gap between
chronological and biological age estimation. This is achieved
by, first, introducing a new DL framework for organ-specific
CA estimation using 3D medical imaging data. The perfor-
mance of this framework is validated by a quantitative compar-
ison with other concurrent CA estimation networks for brain
age estimation. Additionally, a novel iterative training strategy
is presented as an initial solution for approximating organ-
specific BA labels. This is achieved by identifying outliers
who exhibit atypical-aging characteristics. These outliers are
then segregated from the training dataset. A serious challenge
presents itself on how to validate the accuracy of the utilized
training approach. To this end, we apply the proposed method-
ology on a dataset containing both healthy and Alzheimer’s
affected patients. Subsequently, we quantify the amount of
TABLE I
Age-Net Architecture.
Layer Output shape # Parameters
Input (Brain 3D chunk) 121× 145× 12× 1 —
Inception stem network 16× 19× 12× 192 445k
Inception block - 3b 16× 19× 12× 256 1.42M
Inception block - 3c 16× 19× 12× 480 3.18M
Fire Module (α = 16, β = 64) 16× 19× 12× 128 36.8k
Inception block - 4b 8× 10× 12× 512 5.33M
Inception block - 4c 8× 10× 12× 512 1.96M
Fire Module (α = 16, β = 64) 8× 10× 12× 128 36.8k
Inception block - 4d 8× 10× 12× 512 5.68M
Inception block - 4e 8× 10× 12× 528 6.04M
Fire Module (α = 16, β = 64) 8× 10× 12× 256 141k
Inception block - 4f 4× 5× 6× 832 9.70M
Inception block - 5b 4× 5× 6× 832 5.47M
Fire Module (α = 32, β = 256) 4× 5× 6× 512 524k
Global average pooling 512 —
Dense layer 1 512 260k
Dense layer 2 256 130k
Dense layer 3 128 32k
Regression layer 1 129
# parameters (total) — 41M
Alzheimer’s patients detected as atypically-aging patients by
the iterative strategy. Statistical and visual analysis of the
results is conducted to illustrate the merit and limitations of
the proposed methodology.
This paper is organized as follows: Sec. II describes the
proposed CA estimation network together with the conducted
comparative study and the corresponding results. Sec. III
presents the iterative data-cleaning strategy for BA estimation
and describes the conducted experimental evaluations. Finally,
Sec. IV presents the results and discussions for the BA
framework followed by the conclusion in Sec. V.
II. CHRONOLOGICAL AGE ESTIMATION
In this section, the proposed DL architecture for organ-
specific CA estimation is introduced. This network is later
utilized as the foundation of the proposed iterative training
strategy for BA estimation. A detailed description of the
experiments conducted to validate the proposed architecture
is presented.
A. Architectural Details
The proposed network for CA estimation, hereby referred
to as Age-Net, is illustrated in Fig. 1a. Based on an ex-
tensive assessment of different state-of-the-art DL structures,
including ResNeXt [48] and DenseNets [49] among others,
the proposed regression network was constructed out of a
hybrid combination of inception v1 [50] and SqueezeNet [51]
architectures.
The inception modules are based on the concept of split-
transform-merge strategy where each module is comprised
of parallel filters with different kernel dimensionality, which
results in a network growing wider instead of deeper. This
enables learning deeper feature representations by increasing
the capacity of the network while mitigating the increased
computation budget associated with network depth [50]. In
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Fig. 2: Distribution of the open-source brain IXI MR datset. The
dataset covers diverse age categories with a mean of µ ≈ 48 years
and a standard deviation of σ ≈ 16 years.
this work, we utilize the inflated inception v1 architecture,
which is a 3D realization of conventional inception modules
achieved via inflating all filters and pooling kernels into their
3D counterparts [52]. An illustration of an inflated inception
module is illustrated in Fig. 1b.
Additionally, fire modules proposed in SqueezeNet are also
incorporated in the Age-Net architecture [51]. They consist
of squeeze-and-expand layers comprised of a combination
of 1 × 1 × 1 and 3 × 3 × 3 convolutions that help reduce
the total number of trainable parameters while enhancing the
representation capacity. An illustration of the fire modules is
depicted in Fig. 1c.
The final architecture for Age-Net is composed of an initial
stem network consisting of 3 × 3 × 3 convolutions and max-
pooling layers. This is followed by four modules concatenated
together in an end-to-end manner. Each module consists
of two inception blocks followed by a single fire module.
In the above modules, each convolutional layer is followed
by batch normalization and a ReLU activation function. L2
regularization is additionally utilized for each convolutional
layer. A global average pooling layer is then applied as a
structural regularizer to reduce the four-dimensional tensor to
a one-dimensional output vector of 512 features. Finally, three
dense layers combine additional gender information before a
final regression layer outputs the predicted age. The complete
architectural details of the Age-Net are outlined in Table I.
Kernel parameters for the different inception blocks can be
found in the original inception v1 publication [51].
B. Input Pipeline
Empirically, the method of feeding the input MR volumes
to the Age-Net was found to have a significant impact on
the network performance. Thus, two different approaches of
feeding the 3D volumes are investigated in this work. First,
entire MR volumes are fed as inputs to the network, which
produces a single predicted age for each test subject. Due to
the relatively limited number of training patients, data augmen-
tation is essential to prevent network overfitting. Accordingly,
horizontal flipping and translating the input volumes within
(a) (b)
Fig. 3: Examples of input brain GM from the axial orientation for
(a) 23 year old subject, (b) 86 year old subject.
a pre-defined voxel-range (30 × 30) in the axial orientation
were incorporated in the input pipeline. Despite its simplicity,
this approach comes with a significant cost on the training
efficiency due to the large memory space required as well as
the on-the-fly data augmentations.
The second data feeding strategy entails dividing the input
MR volumes into smaller 3D chucks and then feeding each
chunk separately. This implicitly augments the training process
by expanding the number of input samples to the network,
thus, negating the need for on-the-fly data augmentations. The
final predicted score for a test subject is then given as the
mean of the predicted ages for the different input chunks.
In addition to being advantageous from a training efficiency
perspective, we hypothesize that this approach could assist
in the unsupervised localization of anomalies and lesions per
chunk. This can be achieved by investigating irregularities in
the prediction scores for individual chunks compared to the
CA ground-truth label for each test subject. However, this
hypothesis will be further investigated in the future.
C. Dataset and Pre-processing
The proposed Age-Net architecture is evaluated on the task
of estimating organ-specific CA for the brain region. For this
purpose, we utilize the open source IXI dataset for brain MR
scans [53]. T1-weighted MR scans with an original matrix size
of 256 × 256 × 150 voxels from 562 subjects were utilized.
The scans were acquired according to a flip angle of 8, echo
time of 4.6 ms and a repetition time of 9.8 ms. Scans from
420, 92 and 50 subjects were used for training, validation and
testing, respectively. This was achieved while maintaining a
balanced number of scans from all age-groups in all data
subsets. For pre-processing, we utilize the steps recommended
in [54], [55]. As a first step, all 3D volumes were realigned
to provide a common orientation for brain visualization. This
was achieved by utilizing the canonical Montreal Neurological
Institute (MNI) 152 template adopted by the International
Consortium for Brain Mapping (ICBM) [54]. Since the Gray
Matter (GM) content of the brain was previously proven
to be a strong indicator of the brain age [56], the GM
content of the aligned brain volumes was segmented using
the statistical parameter mapping 12 (SPM12) software [57].
The resulting tissue maps were registered using DARTEL [58]
followed by normalization and modulation using a Jacobian
deformation map. The resultant final GM volumes are of size
121 × 145 × 121 voxels. The CA histogram for the utilized
TABLE II
Quantitative comparison for CA estimation.
Model MAE SD Bias RMSE Corr.
2D-Huang [39] 3.529 4.302 1.250 4.480 0.969
3D-Ueda [59] 3.705 4.298 1.268 4.481 0.969
Age-Net-Volume 2.658 3.532 0.608 3.584 0.979
Age-Net-Chunk 2.283 3.546 0.902 3.659 0.978
Age-Net-Gender 1.955 3.169 0.511 3.210 0.983
brain MR volumes is depicted in Fig. 2 and example images
are illustrated in Fig. 3.
D. Experiments
The proposed Age-Net architecture for CA estimation is
investigated for the two different data feeding strategies de-
scribed above. The first variant (Age-Net-volume) involves
feeding the entire MR volume as input to the network. In
contrast, the second variant (Age-Net-chunk) feeds smaller
3D chunks as inputs instead. Each volume is divided into
20 non-overlapping xx chunks of matrix size 121× 145× 6.
Additionally, we hypothesize that including additional meta-
information about the test subjects, i.e. gender, would assist
in enhancing the age-regression performance. As such, an
additional experiment was conduced to investigate the effect
of including the gender (Age-Net-gender) with the chunk data
feeding strategy.
To demonstrate the performance of Age-Net, quantitative
comparisons were conduced against other regression networks
previously proposed for brain MRI CA estimation. First,
we compared against the framework provided in [39] (2D-
Huang) that consists of a modified deep VGG-Net [60]. Also,
comparisons were conduced against a state-of-the-art brain
age regression framework (3D-Ueda) [59]. This network is
comprised of four 3D convolutional blocks together with max
pooling and dense layers. All networks were trained until
convergence to minimize the mean absolute error (MAE) loss
function on a single NVIDIA Titan-X GPU using the Adam
optimizer [61] with Nesterov momentum (0.9) and a learning
rate of 10−4. All implementations of Age-Net will be made
publicly available upon the publication of this work1. Several
metrics were calculated for the quantitative comparisons: the
MAE, standard deviation (SD), bias, root mean square error
(RMSE) and the correlation coefficient (Corr.) between the
predicted ages and the ground-truth CA labels.
E. Results
The results of the CA estimation for the IXI brain dataset
are presented in Table II and Fig. 4. The current approaches by
Huang [39] and Ueda [59] exhibit comparable performance.
The proposed 3D Age-Net architecture outperformed these
two concurrent approaches across the utilized metrics. Feeding
an entire MR volume as input enhanced the MAE to 2.66
years with a lower bias of 0.6 years and an improved RMSE
of 3.58 years. Additionally, adapting the input pipeline to
1https://github.com/KarimArmanious
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Fig. 4: Statistical analysis and comparison between the networks proposed in literature and the proposed Age-Net with the chunk-based
feeding strategy. The Age-Net approach outperforms the concurrent MRI-based CA estimation approaches across the investigated metrics.
Fig. 5: An overview of the iterative data-cleaning strategy idea where
atypical outliers (BA 6≈ CA) are segregated from the training data.
Thus, the Age-Net (with the chunk data feeding strategy) is trained
with only typical-aging dataset (BA ≈ CA).
accommodate smaller 3D chunks instead of a full volume
improved the MAE further by approximately 0.4 years albeit
with an increased bias of 0.9 years. Furthermore, including
the gender information with the chunk data feeding strategy
resulted in the best quantitative scores represented by MAE of
1.96 years, the lowest systematic error of 0.51 years in bias and
the smallest RMSE of 3.2 years. An interesting observation
regarding the quantitative metrics is that all different CA
estimation approaches result in positive bias values. This
indicates the tendency of the investigated test subjects to
exhibit accelerated aging characteristics.
III. BIOLOGICAL AGE ESTIMATION
The main challenge for image-based BA estimation is the
lack of ground-truth labels since BA is not clearly defined [18],
[19]. As such, previous approaches attempting this task had
to, instead, rely on utilizing CA labels [43]–[45]. However,
aging is an organ-specific process affected by a multitude of
factors such as lifestyle and genetics. Thus, utilizing CA as
ground-truth will not provide results that are indicative of the
true aging features of the organs in question. Another option is
to rely on subjective evaluations by radiologists. Nevertheless,
this time-consuming and subjective process is challenging for
large datasets and depends on the relative experience of the
radiologists as it is not possible to accurately label the BA.
To resolve this challenge, we propose an iterative data-
cleaning strategy to approximate BA labels. This is achieved
by iteratively identifying and subsequently removing outliers
that exhibit atypical-aging characteristics, whether accelerated
(BA > CA) or delayed aging (BA < CA). The rationale be-
hind this approach is to arrive at a typical-aging dataset in
which the CA labels resemble the true BA labels (BA ≈ CA).
We hypothesize that training on this dataset should help to
bridge the gap from chronological to biological age estimation.
Since the Age-Net-Gender framework was proven in the pre-
vious section to result in the best quantitative CA estimation,
we herby utilize this approach as the baseline for the following
BA estimation approach. For simplicity, we herby refer to this
architecture as “Age-Net”. A basic outline of this strategy is
depicted in Fig. 5. In the next sections, the introduced iterative
data-cleaning strategy and the outlier detection procedure are
further defined.
A. Iterative Data-Cleaning Strategy
A step-wise overview of the iterative data-cleaning strategy
for BA estimation is illustrated in Fig. 6. Initially, the available
brain MR scans were divided into training and testing datasets.
Care was taken so that the training subjects represent the
entirety of the available age spectrum in a balanced manner.
For each iteration, the first step is to shuffle and split
the training data into two subsets. The first subset is used
to train an Age-Net architecture utilizing the chunk data
feeding strategy with gender information (Age-Net-Gender)
till convergence. This input pipeline was chosen as it showed
the best results for CA estimation, as described above in
Sec. II. The trained model is then validated on the second
subset and the estimated CAs ( ĈA ) for the different patients
is used to calculate a patient-dependent threshold γBA. This
Fig. 6: A detailed flow chart of the proposed iterative data-cleaning strategy for the extraction of BA labels.
threshold is then utilized for the detection of outliers who
exhibit atypical-aging characteristics in the validation subset.
The process of threshold calculation and outlier detection is
explained in more details in the next subsection. The identified
patients are then flagged as outliers. A new iteration would
then be repeated starting with merging the validation samples
with the training subset, reshuffling and repeating the process
by training the Age-Net framework from scratch.
At the end of an iteration, if no outliers are detected
in the validation subset, two arguments could be presented.
First, the dataset has been thoroughly filtered out with all
atypically-aging patients identified as outliers. Thus, no further
refinement of the dataset is possible. Another explanation is
that despite the lack of outliers in the validation data, some
could still exist in the training subset. To protect against this
possibility, an empirical stopping condition is enabled that
states that three consecutive data-cleaning iterations trained
with different initializations must yield no new outliers before
the iterative strategy can be terminated.
Upon termination of the data-cleaning algorithm, all patients
who were flagged as outliers in more than one iteration are
removed from the training dataset. This serves to assert that
no typically-aging patient is wrongfully detected as an outlier.
Also, this process assists in maintaining the training data
distribution during the data-cleaning strategy. Finally, an Age-
Net architecture is trained on the cleaned dataset (after the
removal of the outliers) where the CA labels should correspond
approximately to the true BA labels (BA ≈ CA).
B. Outlier Detection
In this work, we utilize a chunk data feeding strategy were
each input MR volume is divided into K smaller chunks before
being fed as input to the Age-Net. Outlier detection is initiated
by first calculating a consolidated CA estimate for each patient
in the validation dataset. This is achieved by averaging out the
predicted ages (ĈAn,i) for each chunk i in the MR volume of
patient n as:
ĈAn =
1
K
K∑
i=1
ĈAn,i (1)
Additionally, the standard deviation for the different chunk
predictions is calculated for each patient as:
σn =
√√√√ 1
K
K∑
i=1
(
ĈAn,i − ĈAn
)2
(2)
This is repeated for all patients to obtain the vectors:
ĈA =

ĈA1
ĈA2
...
ĈAN
 , σ =

σ1
σ2
...
σN
 (3)
where N is the total number of patients in the validation
dataset. For outlier detection, we compare the predicated age
deviations (D) against a patient-dependent threshold (γBA),
both defined as:
D =
∣∣∣ĈA− CA∣∣∣ , γBA = R · σ (4)
where R is a pre-defined constant value. The nth patient is
flagged as an outlier only if the age deviation exceeds the
corresponding threshold value:
Dn > γBA,n (5)
Assuming a normal distribution for the chunk predictions,
the arbitrary constant R was set to 1.96 to reflect the 95%
confidence interval of the mean predicted age of each patient,
as illustrated in Fig. 7. At the end of each iteration, the training
and validation datasets are reshuffled and a new iteration
commences until the stopping condition is reached. Upon
termination of the iterative data-cleaning, all patients detected
as outliers are removed from the final training dataset only
95%
Confidence Interval
−1.96σ 1.96σ
ĈACA
Fig. 7: Illustration of the outlier detection threshold γBA,n.
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Fig. 8: Histogram of the utilized subset from the OASIS-3 MR
dataset. Data balancing was performed with respect to the number
of data samples in the different age groups to ensure the Age-Net
is trained on a class-balanced dataset ( ). The remaining data
samples were allocated to the test dataset.
if they were flagged in more than one iteration. The final
framework is then trained on a dataset containing only patients
exhibiting typical-aging characteristics.
C. Dataset
Due to the lack of reference ground-truth BA labels, the
validation of the proposed iterative data-cleaning strategy
poses a key challenge. For this purpose, we investigate the
performance of the introduced training strategy on a class-
balanced subset from the OASIS-3 brain dataset [62]. This
dataset encompasses T1-weighted MR scans from anonymized
cognitively healthy individuals as well as patients suffering
from dementia due to Alzheimer’s disease. The scans were
acquired according to a flip angle of 10, echo time of 4
ms and a repetition time of 9.7 ms. The degree of cognitive
deterioration in the Alzheimer’s patients is indicated by the
clinical dementia rating (CDR), which distinguishes between
questionable, mild and moderate dementia by the CDR scores
of 0.5, 1 and 2, respectively [63].
In total, we utilize a subset of 1230 MRI scans from 950
patients in the age-range of 48-97 years. To ensure that the
Age-Net is trained on a class-balanced dataset, we allocate
565 MR scans from 405 healthy patients and 185 scans from
165 Alzheimer’s patients for training the proposed framework.
The remaining 490 scans from 380 patients (270: healthy, 110:
Alzheimer’s) are assigned as the test set. The histogram of
the utilized OASIS-3 data is depicted Fig. 8. The same pre-
processing pipeline described previously in Sec. II-C was also
applied with MR chunks of matrix size 121× 145× 6 being
fed to the framework as inputs.
D. Experiments
In previous studies, it has been reported that Alzheimer’s
disease correlates directly with abnormal brain characteristics,
particularly accelerated aging [31]. We apply this observation
as an attempt to evaluate the capability of the iterative data-
cleaning strategy in detecting atypically-aging individuals.
More specifically, we count the number of patients flagged as
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Fig. 9: The cumulative number of outliers detected during the iterative
data-cleaning strategy with respect to the total number of patients in
the training dataset from the corresponding clinical dementia rating
(CDR) levels. Annotated is the amount of outliers/total number of
patients in each CDR level.
outliers by the proposed training strategy. Further, we analyze
the percentage of cognitively healthy individuals (CDR = 0)
and Alzheimer’s patients (CDR = 0.5, 1, 2) detected as outliers
with respect to their corresponding populations in the training
dataset. We hypothesize that the proposed training strategy
should be capable of accurately detecting patients with mild
and moderate dementia as those theoretically exhibit the most
pronounced atypical-aging characteristics.
Additionally, we compare the final predicted BAs, after
applying the iterative data-cleaning framework, against the age
estimates from an Age-Net trained by using CA as ground-
truth labels. We illustrate, and subsequently analyze, the distri-
butions of the resultant age estimates of the two frameworks.
This was conducted separately for both cognitively healthy
and Alzheimer’s patients.
Motivated by the recent interest in providing explainable DL
frameworks, we attempt to shed light onto the reason beyond
the predicted BA decision of our proposed network. For this
purpose, we employ recent DL visualization techniques to
highlight the most significant brain regions accounting to
the network’s prediction from patients labelled as outliers or
healthy by the iterative strategy. Specifically, we utilize at
inference a combination of saliency-map visualizations [64],
[65] together with GradCAM++ [66] for more fine grained
visualization map. The resultant outputs of each visualization
technique are combined via a product operation to obtain the
final visualization maps. We compare the differences between
the visualization maps from healthy and Alzheimer’s patients
in the same age groups. Also, we analyze the visualizations of
cognitively healthy individuals (CDR = 0) who were deemed
by the framework as exhibiting atypical-aging characteristics,
thus flagged as outliers.
It is important to note that the results of these visualization
techniques does not refer directly to the actual brain biological
activity. Rather, it is utilized as means to explain the network’s
decisions and highlight the differences between the results of
healthy and outlier patients.
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Fig. 10: The PDF of the deviations between the estimated ages and the ground-truth CA labels. The depicted lines ( ) and ( )
represents the best-fit distribution for the CA and BA networks, respectively.
IV. RESULTS AND DISCUSSION
The first step towards analyzing the proposed iterative data-
cleaning strategy is to examine the detected outliers across
consecutive iterations. As depicted in Fig. 9, a total of 18
training iterations were conducted before termination. This is
due to satisfying the pre-defined stopping condition with no
outliers detected in three successive iterations. Upon examin-
ing the population of patients with moderate dementia (CDR
= 2, ), it is observed that the proposed strategy detects all
aforementioned patients after 11 iterations. For Alzheimer’s
patients with mild dementia ( ), 36 out of 49 patients
were flagged as outliers in 16 iterations, amounting to a total
of 73% of the CDR 1 training population. For questionable
dementia (CDR = 0.5, ), 54% of this population were
detected as outliers in 15 iterations. Conversely, for cognitively
healthy individuals ( ) a substantially smaller percentage
of patients (25%) were flagged as outliers. Compared to the
number of outliers detected from Alzheimer’s patients, it is
realistic for cognitively healthy individuals to less frequently
exhibit atypically-aging characteristics. The above findings
indicate that this training algorithm is capable of detecting
atypical-aging characteristics whether Alzheimer’s-related or
not. This demonstrates that the proposed training strategy
is not only restricted to Alzheimer’s detection but reveals a
higher generalizable potential. For instance, it can potentially
be extended to different sources of brain deterioration such
as tumours and lesions. Subsequently, all flagged outliers are
removed from the training samples to create a typical-aging
dataset (BA ≈ CA). Thereafter, an Age-Net framework is
trained for the task of BA estimation using this filtered dataset.
Additionally, we also compare the predicted ages of the pro-
posed BA estimation framework (after iterative data-cleaning)
against those from a conventionally trained CA estimation
Age-Net. The probability distribution functions (PDFs) of the
deviations between the predicted ages and ground-truth CA
labels for both frameworks are presented in Fig. 10. For the
cognitively healthy population, minor perceivable differences
can be observed in the distributions of both frameworks.
This is illustrated in Fig. 10a with both of them adopting a
normal distribution with a mean-deviation shift of 0.92 years.
However, in Fig. 10b the predicted BA ages for Alzheimer’s
patients manifest a substantially different behavior with a mul-
timodal distribution ( ) as opposed to a normal distribution
( ) by the CA framework. Since Alzheimer’s disease was
found to correspond with abnormal brain aging [31], it follows
that the predicted BA scores for patients with dementia must
exhibit a significant deviation from the corresponding CA
labels. This desired behavior is signified in the proposed BA
estimation framework with the majority of the predicted ages
exhibiting an over-aging of approximately 8.2 years compared
to the CA framework. We hypothesize that this reflects the
capability of the proposed framework in recognizing true BA
behavior. Also, a relatively smaller population of Alzheimer’s
patients reveals under-aging behavior.
For the final set of experimental evaluations, we analyze
the visualization maps from patients identified by the data-
cleaning strategy as exhibiting atypical-aging characteristics.
Thus, these patients were removed from the final BA training
dataset. It is important to distinguish that these visualization
maps reflects the network predictions rather than the actual
brain voxel intensities. We also compare the resultant outlier
visualization maps against those extracted from healthy indi-
viduals. As shown in Fig. 11, cognitively healthy individuals
exhibit strong activations in the amygdala, hippocampus and
thalamus in the axial plane as indicated by ( ). This agrees
with prior work investigating voxel-based morphometry of
brain MRI of healthy patients [55]. In contrast, patients suffer-
ing from dementia (CDR > 0) identified as outliers manifest
relatively weaker activations in the same regions, as indicated
by ( ). However, it is interesting to point out that cognitively
healthy patients who were flagged as outliers (CDR = 0) reveal
a noteworthy behavior. In some instances, the visualization
maps from the aforementioned patients closely resemble the
maps from dementia patients with similar highlighted regions
of low intensity. For other outlier patients of CDR 0, the
resultant visualization maps exhibit unconventional behavior
with different highlighted regions of high intensity compared
to cognitively healthy patients. For example, the regions in
Fig. 11: Examples of the brain visualization maps for 3 axial chunks from healthy and outlier patients as detected by the proposed iterative
strategy. Each column represents scans from a patient of the annotated CA value. The prominent activations in healthy patients were
highlighted by ( ) whereas the corresponding activations in Alzheimer’s patients were labelled via ( ). Uncommon or unique activations
detected in cognitively healthy outliers were labelled by ( ).
and around the fusiform gyrus depicts high activations in the
outlier patients, as specified by ( ), in contrast to healthy
individuals. On the whole, Alzheimer’s patients generally
exhibit weakened networks activations compared to healthy
individuals. Also, the CDR 0 outlier patients are either similar
to dementia patients or display unique activations. We are of
the opinion that the study of the activated brain regions for
outliers could potentially prove to be beneficial for radiologists
as it may assist in the early detection of disorders along with
other various applications.
This initial study reveals the potential of utilizing MRI scans
for BA estimation. The concept of incorporating an iterative
training algorithm for approximating brain BA labels shows
merit by detecting the majority of patients with moderate and
mild dementia as outliers. This does not come at the expense of
an overt detection of cognitively healthy patients as atypically-
aging. Additionally, a visualization study highlighted the pos-
sibility of utilizing the proposed BA estimation framework to
discover the deviation of seemingly healthy patients from their
respective age groups.
As this study is among the first of its kind, our work has
raised more questions than it has provided answers. Further
clinical assessments by radiologists are necessary for the
validation of the introduced framework. More specifically,
a key question is the applicability of the BA framework
on expanded MRI datasets from various organ systems with
different disorders. This could be a step towards achieving an
organ-specific BA assessment for patients using the whole-
body MRI scans. This serves to evaluate the accelerated or
delayed-aging characteristics of various organs within patients.
The correlation between the deviations of the estimated BA
scores and the presence of different disorders should be
studied by radiologists together with the resultant visualization
maps. Additionally, in the future, we plan to investigate the
possibility of utilizing the BA visualization maps for anomaly
detection of lesions and disorders in an unsupervised setting.
V. CONCLUSION
In this work, we present an initial study for organ-specific
BA estimation using MRI scans. As an initial step, we de-
velop a CA estimation framework capable of outperforming
the current state-of-the-art MRI-based regression networks.
Furthermore, we introduce a novel iterative training algorithm
for excluding outlier patients exhibiting atypical-aging char-
acteristics. This leads to the creation of a reference dataset
where the available CA labels reflect the BA behavior. Upon
validating the proposed BA framework on an Alzheimer’s
dataset, the majority of patients with mild or moderate de-
mentia were accurately detected as outliers. Moreover, the
framework was found to be effective in detecting accelerated
aging in Alzheimer’s patients in comparison to conventional
CA estimation. Finally, an analysis was performed using estab-
lished DL visualization techniques which reflects the potential
of the introduced framework in discovering deviations of
seemingly healthy patients from their respective age groups.
In the future, we plan to expand the proposed framework via
the utilization of recent advances in Bayesian neural networks
and uncertainty detection techniques to enhance the outlier
detection procedure. Also, extension to different organ systems
with whole-body MRI data would be investigated.
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